rs3219170

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_020919.4(ALS2):​c.4581-48T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.922 in 1,485,640 control chromosomes in the GnomAD database, including 631,949 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.89 ( 61068 hom., cov: 32)
Exomes 𝑓: 0.92 ( 570881 hom. )

Consequence

ALS2
NM_020919.4 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 0.198

Publications

9 publications found
Variant links:
Genes affected
ALS2 (HGNC:443): (alsin Rho guanine nucleotide exchange factor ALS2) The protein encoded by this gene contains an ATS1/RCC1-like domain, a RhoGEF domain, and a vacuolar protein sorting 9 (VPS9) domain, all of which are guanine-nucleotide exchange factors that activate members of the Ras superfamily of GTPases. The protein functions as a guanine nucleotide exchange factor for the small GTPase RAB5. The protein localizes with RAB5 on early endosomal compartments, and functions as a modulator for endosomal dynamics. Mutations in this gene result in several forms of juvenile lateral sclerosis and infantile-onset ascending spastic paralysis. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2008]
ALS2 Gene-Disease associations (from GenCC):
  • ALS2-related motor neuron disease
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • amyotrophic lateral sclerosis type 2, juvenile
    Inheritance: AR Classification: STRONG Submitted by: Genomics England PanelApp
  • infantile-onset ascending hereditary spastic paralysis
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Orphanet
  • juvenile primary lateral sclerosis
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Orphanet
  • juvenile amyotrophic lateral sclerosis
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BP6
Variant 2-201705509-A-G is Benign according to our data. Variant chr2-201705509-A-G is described in ClinVar as Benign. ClinVar VariationId is 261379.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.962 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ALS2NM_020919.4 linkc.4581-48T>C intron_variant Intron 29 of 33 ENST00000264276.11 NP_065970.2 Q96Q42-1A8K4R4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ALS2ENST00000264276.11 linkc.4581-48T>C intron_variant Intron 29 of 33 1 NM_020919.4 ENSP00000264276.6 Q96Q42-1

Frequencies

GnomAD3 genomes
AF:
0.894
AC:
136002
AN:
152088
Hom.:
61021
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.819
Gnomad AMI
AF:
0.981
Gnomad AMR
AF:
0.882
Gnomad ASJ
AF:
0.914
Gnomad EAS
AF:
0.984
Gnomad SAS
AF:
0.959
Gnomad FIN
AF:
0.961
Gnomad MID
AF:
0.870
Gnomad NFE
AF:
0.919
Gnomad OTH
AF:
0.880
GnomAD2 exomes
AF:
0.923
AC:
221992
AN:
240488
AF XY:
0.928
show subpopulations
Gnomad AFR exome
AF:
0.821
Gnomad AMR exome
AF:
0.893
Gnomad ASJ exome
AF:
0.916
Gnomad EAS exome
AF:
0.986
Gnomad FIN exome
AF:
0.954
Gnomad NFE exome
AF:
0.921
Gnomad OTH exome
AF:
0.920
GnomAD4 exome
AF:
0.925
AC:
1233347
AN:
1333434
Hom.:
570881
Cov.:
19
AF XY:
0.927
AC XY:
621142
AN XY:
670362
show subpopulations
African (AFR)
AF:
0.825
AC:
25139
AN:
30478
American (AMR)
AF:
0.890
AC:
39194
AN:
44058
Ashkenazi Jewish (ASJ)
AF:
0.914
AC:
23084
AN:
25258
East Asian (EAS)
AF:
0.991
AC:
38384
AN:
38744
South Asian (SAS)
AF:
0.959
AC:
79229
AN:
82654
European-Finnish (FIN)
AF:
0.954
AC:
50627
AN:
53080
Middle Eastern (MID)
AF:
0.904
AC:
4352
AN:
4816
European-Non Finnish (NFE)
AF:
0.923
AC:
921869
AN:
998496
Other (OTH)
AF:
0.922
AC:
51469
AN:
55850
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
4692
9383
14075
18766
23458
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
18568
37136
55704
74272
92840
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.894
AC:
136108
AN:
152206
Hom.:
61068
Cov.:
32
AF XY:
0.898
AC XY:
66792
AN XY:
74406
show subpopulations
African (AFR)
AF:
0.819
AC:
33995
AN:
41514
American (AMR)
AF:
0.882
AC:
13486
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.914
AC:
3171
AN:
3470
East Asian (EAS)
AF:
0.985
AC:
5106
AN:
5186
South Asian (SAS)
AF:
0.959
AC:
4621
AN:
4818
European-Finnish (FIN)
AF:
0.961
AC:
10196
AN:
10612
Middle Eastern (MID)
AF:
0.878
AC:
258
AN:
294
European-Non Finnish (NFE)
AF:
0.919
AC:
62524
AN:
68006
Other (OTH)
AF:
0.880
AC:
1856
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
723
1446
2170
2893
3616
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
904
1808
2712
3616
4520
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.904
Hom.:
12044
Bravo
AF:
0.885
Asia WGS
AF:
0.958
AC:
3327
AN:
3474

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jul 03, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Infantile-onset ascending hereditary spastic paralysis Benign:1
Jul 14, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Juvenile primary lateral sclerosis Benign:1
Jul 14, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Amyotrophic lateral sclerosis type 2, juvenile Benign:1
Jul 14, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.90
CADD
Benign
4.1
DANN
Benign
0.78
PhyloP100
0.20
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3219170; hg19: chr2-202570232; API